Abstract: In some embodiments, an X-ray system comprises a work-station and a mammography apparatus. The mammography apparatus can comprise: a breast positioning area; an absorption contrast imaging apparatus; and a diffractometer for analyzing structure of tissue within a breast. The absorption contrast imaging apparatus and the diffractometer can be configured to move in order to interchangeably align with the breast positioning area. The work-station can be configured to control the mammography apparatus, and to process data received from the mammography apparatus.

Abstract: In some embodiments an X-ray system comprises a work-station and a mammography apparatus. The mammography apparatus can comprise: a breast positioning area; a diffraction enhanced X-ray imaging apparatus; and a diffractometer for analyzing structure of tissue within a breast. The diffraction enhanced X-ray imaging apparatus and the diffractometer can be configured to move in order to interchangeably align with the breast positioning area. The work-station can be configured to control, and to process data received from, the mammography apparatus.

Abstract: An X-ray diffractometer system analyzes objects including biological tissue samples and physical and chemical samples. The diffractometer system includes an X-ray beam projector that projects an incident micro-beam of X-ray at an analysis target, an X-ray receiver including an X-ray detector array to detect the transmitted X-rays passed through the object and X-rays that the target diffracts, and a computer workstation for system control and data analysis. The X-ray beam projector may include a radiation source, a beam forming system including at least one of a monochromator, a collimator, and focusing device. The computer workstation may control the X-ray devices and positioning mechanisms and motors, may acquire, process, store, or display data received from diffractometric examination, and may also calculate parameters of the three-dimensional reciprocal lattice of the analyzed target.

Abstract: An x-ray diffractometer may perform 3D-analysis of collagen tissue of a patient (a human or another animal). The diffractometer includes an oblong housing that may be hinged and that contains an x-ray projector on one side of a recess and a receiver on an opposite side of the recess. The recess accommodates analyzed tissue such as the external ear and skin of a patient. The x-ray projector directs an x-ray micro-beam at the patient's tissue, and the receiver contains a movable two-dimensional x-ray detector that detects a transmitted x-ray micro-beam passed through the analyzed tissue and detects x-rays scattered or diffracted by the analyzed tissue.

Abstract: The present disclosure relates to determining an efficacy of a therapeutic agent. A method for determining an efficacy of a therapeutic agent for a target disease can include measuring a molecular structure of a biological tissue of an animal at a first time and at a second time using a non-invasive biological tissue characterization technique. The method can further include observing a change of the molecular structure of the biological tissue between the first time and the second time, and determining the efficacy of the therapeutic agent based on the observed change in the molecular structure of the biological tissue. Before the first time, or between the first time and the second time, the animal received the therapeutic agent.

Abstract: The present disclosure relates to determining a therapy efficacy. A method for determining an efficacy of a therapy for a disease in an animal patient can include measuring a molecular structure of a biological tissue of an animal patient at a first time and at a second time using a non-invasive biological tissue characterization technique. The method can further include observing a change of the molecular structure of the biological tissue between the first time and the second time, and determining the efficacy of the therapy based on the observed change in the molecular structure of the biological tissue. Before the first time, or between the first time and the second time, the animal patient received the therapy.

Abstract: The present disclosure relates to determining a biological tissue structural marker for diagnosis of a disease using a biological tissue characterization technique. A method for determining a structural marker for a diagnosis of a disease can include measuring a first molecular structure of a biological tissue of a first population of animals, after a carcinogenic or pathogenic substance was introduced into the first population. A second molecular structure of the biological tissue of a second population of animals can be measured, wherein the second population did not receive the carcinogenic or pathogenic substance. A first and a second structural marker of the molecular structures of the biological tissue of the first and second populations, respectively, can be identified and compared to determine that the first structural marker is indicative that the biological tissue of the first population of animals was affected by the disease.

Abstract: The present disclosure provides device having a reaction vessel with one or more permeable membranes disposed therein that separate the reaction vessel into at least a first portion and a second portion. The one or more membranes permit first reactants from a first solution in the first portion or reactants from a second solution in the second portion to seep or percolate to a reaction zone proximate a surface of the one or more membranes. A reaction of the first and second reactants forms a two-dimensional polymer film material. A roller located inside of the reaction vessel draws the two-dimensional polymer film material reaction out of the reaction zone.

Abstract: Diffractometer-based global in vitro diagnostic systems or methods may use one or more diffraction apparatuses for the structural analysis of ?-keratin and collagen in samples of hair, nails, skin, internal organs, or other tissue of a human or non-human animal. The diffraction apparatuses operatively couple to a computer database and provide sample data including diffraction pattern data for in vitro samples or data derived therefrom. One or more computer systems receive or transmit the sample data or data derived therefrom and process the sample data or data derived therefrom to provide a computer-aided diagnostic indicators.

Abstract: The present disclosure provides Lazarev reactor that sustains reaction of two dimensional polymerization on the interface of two immiscible solutions A and B carrying components of reaction to the interface where reaction takes place and produces film of two dimensional polymer layers that are pulled out of reactor and rolled up on roll after drying excess of solvent out.

Abstract: The present disclosure provides device having a reaction vessel with one or more permeable membranes disposed therein that separate the reaction vessel into at least a first portion and a second portion. The one or more membranes permit first reactants from a first solution in the first portion or reactants from a second solution in the second portion to seep or percolate to a reaction zone proximate a surface of the one or more membranes. A reaction of the first and second reactants forms a two-dimensional polymer film material. A roller located inside of the reaction vessel draws the two-dimensional polymer film material reaction out of the reaction zone.

Abstract: The present disclosure provides Lazarev reactor that sustains reaction of two dimensional polymerization on the interface of two immiscible solutions A and B carrying components of reaction to the interface where reaction takes place and produces film of two dimensional polymer layers that are pulled out of reactor and rolled up on roll after drying excess of solvent out.

Abstract: The present disclosure provides device comprising a cylindrical reaction vessel having one or more permeable cylindrical membranes disposed therein separating the cylindrical reaction vessel into at least a first portion and a second portion, wherein the one or more permeable cylindrical membranes are configured to permit first reactants from a first solution in the first portion or reactants from a second solution in the second portion to percolate or seep to a reaction zone proximate a surface of the one or more cylindrical membranes. A lifting device (mechanism) located above the first portion of the cylindrical reaction vessel configured to continuously draw a preform two-dimensional polymer tube formed by continuous reaction of the first and second reactants out from the reaction zone.